Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-03-01 Sale |
2023-03-01 11:40 am |
COWEN INC. | COWN | Kim Lorence H. Director |
38,236 | $39 | $1,491,204 | 0 (Direct) |
View |
2022-07-22 Purchase |
2022-07-25 4:58 pm |
Revolution Medicines Inc. | RVMD | Kim Lorence H. Director |
50,000 | $20 | $1,000,000 | 60,500 (Direct) |
View |
2022-02-25 Purchase |
2022-02-28 4:31 pm |
COWEN INC. | COWN | Kim Lorence H. Director |
30,000 | $30.03 | $900,849 | 30,000 (Direct) |
View |
2020-05-15 Sale(A) |
2020-06-04 6:33 pm |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
2,600 | $63.8 | $165,880 | 1,219,910 (Direct) |
View |
2020-06-02 Sale |
2020-06-04 6:18 pm |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
241,000 | $58.3 | $14,050,300 | 2,368,617 (Direct) |
View |
2020-05-27 Sale |
2020-05-28 6:07 pm |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
241,000 | $51.13 | $12,322,330 | 1,924,463 (Direct) |
View |
2020-05-15 Sale |
2020-05-19 5:04 pm |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
261,000 | $80.85 | $21,101,992 | 2,165,463 (Direct) |
View |
2020-05-12 Sale |
2020-05-14 5:00 pm |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
241,000 | $64.49 | $15,541,142 | 1,509,032 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-06 Option Award |
2025-03-10 6:07 pm |
N/A N/A |
Cencora Inc. | COR | Kim Lorence H. Director |
789 | $0 | 3,524 (Direct) |
View |
2024-06-20 Option Award(A) |
2024-06-28 5:07 pm |
N/A 2034-06-19 |
Revolution Medicines Inc. | RVMD | Kim Lorence H. Director |
20,203 | $0 | 85,903 (Direct) |
View |
2024-06-20 Option Award |
2024-06-24 4:21 pm |
N/A 2034-06-19 |
Revolution Medicines Inc. | RVMD | Kim Lorence H. Director |
21,500 | $0 | 87,200 (Direct) |
View |
2024-03-12 Option Award |
2024-03-13 4:45 pm |
N/A N/A |
Cencora Inc. | COR | Kim Lorence H. Director |
843 | $0 | 2,735 (Direct) |
View |
2023-06-08 Option Award |
2023-06-12 4:13 pm |
N/A 2033-06-07 |
Revolution Medicines Inc. | RVMD | Kim Lorence H. Director |
23,600 | $0 | 84,100 (Direct) |
View |
2023-03-09 Option Award |
2023-03-13 4:18 pm |
N/A N/A |
AMERISOURCEBERGEN CORP | ABC | Kim Lorence H. Director |
1,334 | $0 | 2,060 (Direct) |
View |
2022-11-01 Option Award |
2022-11-03 5:20 pm |
N/A N/A |
AMERISOURCEBERGEN CORP | ABC | Kim Lorence H. Director |
558 | $0 | 726 (Direct) |
View |
Ownership |
2022-10-07 8:05 pm |
N/A N/A |
AMERISOURCEBERGEN CORP | ABC | Kim Lorence H. Director |
0 | $0 | 168 (Indirect) |
View |
2022-08-30 Option Award |
2022-09-01 4:20 pm |
N/A N/A |
COWEN INC. | COWN | Kim Lorence H. Director |
8,184 | $0 | 38,184 (Direct) |
View |
2022-07-12 Option Award |
2022-07-13 5:02 pm |
N/A 2032-07-11 |
Revolution Medicines Inc. | RVMD | Kim Lorence H. Director |
47,300 | $0 | 47,300 (Direct) |
View |
2020-06-02 Exercise |
2020-06-04 6:18 pm |
N/A N/A |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
162,691 | $19.15 | 2,368,617 (Direct) |
View |
2020-06-02 Exercise |
2020-06-04 6:18 pm |
N/A N/A |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
78,309 | $14.22 | 2,368,617 (Direct) |
View |
2020-06-02 Exercise |
2020-06-04 6:18 pm |
N/A 2028-02-28 |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
241,000 | $0 | 2,368,617 (Direct) |
View |
2020-05-27 Exercise |
2020-05-28 6:07 pm |
N/A N/A |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
18,635 | $12.21 | 1,924,463 (Direct) |
View |
2020-05-27 Exercise |
2020-05-28 6:07 pm |
N/A N/A |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
222,365 | $14.22 | 1,924,463 (Direct) |
View |
2020-05-27 Exercise |
2020-05-28 6:07 pm |
N/A 2027-02-23 |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
241,000 | $0 | 1,924,463 (Direct) |
View |
2020-05-18 Exercise |
2020-05-19 5:04 pm |
N/A N/A |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
211,978 | $12.21 | 2,165,463 (Direct) |
View |
2020-05-18 Exercise |
2020-05-19 5:04 pm |
N/A N/A |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
29,022 | $14.22 | 2,165,463 (Direct) |
View |
2020-05-18 Exercise |
2020-05-19 5:04 pm |
N/A 2028-02-28 |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
241,000 | $0 | 2,165,463 (Direct) |
View |
2020-05-12 Exercise |
2020-05-14 5:00 pm |
N/A N/A |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
11,643 | $12.21 | 1,509,032 (Direct) |
View |
2020-05-12 Exercise |
2020-05-14 5:00 pm |
N/A N/A |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
229,357 | $10.9 | 1,509,032 (Direct) |
View |
2020-05-12 Exercise |
2020-05-14 5:00 pm |
N/A 2026-02-23 |
Moderna Inc. | MRNA | Kim Lorence H. Chief Financial Officer |
241,000 | $0 | 1,509,032 (Direct) |
View |